BMO Capital Upgrades Celanese (CE) Stock, Cites Contributing Factors

On May 20, BMO Capital Markets changed its stance on Celanese Corporation (NYSE:CE)’s stock, upgrading it from an “Underperform” to a “Market Perform” rating and lifting the price target to $55 from $46. The upgrade by the research firm is backed by the shift in risk-reward balance. As per the analysts, while there are macroeconomic and end-market uncertainties, along with its significant debt levels, such challenges have been diminished. The reassessment stems from an easing of tariff wars and the expectation of Celanese Corporation (NYSE:CE)’s balance sheet seeking support from near-term asset sales.

BMO Capital Upgrades Celanese (CE) Stock, Cites Contributing Factors

An interior view of a modern biotechnology laboratory, with a team of researchers in white lab coats.

BMO Capital mentioned that Celanese Corporation (NYSE:CE), which is a chemical and specialty materials company, continues to implement stricter cost control measures. The company has increased cost reduction targets to ~$120 million, which it expects to achieve in 2025. Previously, it announced $80 million in cost reductions, mainly in SG&A productivity. Additionally, Celanese Corporation (NYSE:CE) has identified $40 million in additional cost savings opportunities. These have been evenly split between the Engineered Materials business and the Acetyl Chain business. The company continues to drive self-help measures in support of the strategic priorities, including increased cash to deleverage the balance sheet, intensifying cost improvements, and fueling top-line growth with the help of differentiated business models.

While we acknowledge the potential of CE to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk.  If you are looking for an AI stock that is more promising than CE and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now

Disclosure: None.